Coeptis Therapeutics Holdings, Inc. Quarterly Revenues in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Coeptis Therapeutics Holdings, Inc. quarterly/annual Revenues history and growth rate from Q1 2022 to Q3 2024.
  • Coeptis Therapeutics Holdings, Inc. Revenues for the quarter ending September 30, 2024 was $0.000.
  • Coeptis Therapeutics Holdings, Inc. Revenues for the twelve months ending September 30, 2024 was $0.000.
  • Coeptis Therapeutics Holdings, Inc. annual Revenues for 2023 was $0.000.
  • Coeptis Therapeutics Holdings, Inc. annual Revenues for 2022 was $0.000, a 100% decline from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $0 $0 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $0 $0 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-16
Q1 2024 $0 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q/A 2024-08-16
Q4 2023 $0 $0 $0 Oct 1, 2023 Dec 31, 2023 10-K/A 2024-08-16
Q3 2023 $0 $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $0 $0 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-16
Q1 2023 $0 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-08-16
Q4 2022 $0 $0 Oct 1, 2022 Dec 31, 2022 10-K/A 2024-08-16
Q3 2022 $0 Jul 1, 2022 Sep 30, 2022 10-Q/A 2024-08-16
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q/A 2024-03-25
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q/A 2024-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.